McKesson Corp
LTS : 0JZU$1,004.21+0.28%Oct 16 close
Financials
Income statement · full history
USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
| Reported line item | Apr 1, 2017 to Mar 31, 2018 | Apr 1, 2018 to Mar 31, 2019 | Apr 1, 2019 to Mar 31, 2020 | Apr 1, 2020 to Mar 31, 2021 | Apr 1, 2021 to Mar 31, 2022 | Apr 1, 2022 to Mar 31, 2023 | Apr 1, 2023 to Mar 31, 2024 | Apr 1, 2024 to Mar 31, 2025 | Apr 1, 2025 to Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement [Abstract]era start | |||||||||
| Revenues | 208,357 | 214,319 | 231,051 | 238,228 | 263,966 | 276,711 | 308,951 | 359,051 | 403,430 |
| Cost of sales | (197,173) | (202,565) | (219,028) | (226,080) | (250,836) | (264,353) | (296,123) | (345,728) | (388,880) |
| Gross profit | 11,184 | 11,754 | 12,023 | 12,148 | 13,130 | 12,358 | 12,828 | 13,323 | 14,550 |
| Selling, distribution, general, and administrative expenses | (8,138) | (8,437)R | (9,182)R | (8,849) | (10,537) | (7,776) | (8,657) | (8,507) | (8,096) |
| Claims and litigation charges, net | (82) | (7,936) | (274) | 8 | (147) | (108) | 3 | ||
| Claims and litigation charges, netno longer reported | (37) | (82) | (7,936) | ||||||
| Research and developmentno longer reported | (125) | (71) | (96) | ||||||
| Restructuring, impairment, and related charges, net | (567) | (597) | (268) | (334) | (281) | (209) | (115) | (286) | (245) |
| Goodwill impairment chargesno longer reported | (1,738) | (1,797) | (2) | (69) | 0 | 0 | |||
| Total operating expenses | (10,422) | (10,868) | (9,534) | (17,188) | (11,092) | (7,977) | (8,919) | (8,901) | (8,338) |
| Gains from sales of business and on healthcare technology net asset exchange, netno longer reported | 37R | 0 | 0 | ||||||
| Operating income | 762 | 886 | 2,489 | (5,040) | 2,038 | 4,381 | 3,909 | 4,422 | 6,212 |
| Other income, net | 130 | 182 | 12 | 223 | 259 | 497 | 132 | 202 | 236 |
| Interest expense | (283) | (264) | (249) | (217) | (178) | (248) | (252) | (265) | (247) |
| Loss on debt extinguishmentno longer reported | (122) | 0 | 0 | 0 | (191) | 0 | 0 | ||
| Equity earnings and charges from investment in Change Healthcare Joint Ventureno longer reported | (248) | (194) | (1,108) | 0 | 0 | ||||
| Income before income taxes | 239 | 610 | 1,144 | (5,034) | 1,928 | 4,630 | 3,789 | 4,359 | 6,201 |
| Income tax expense | 53 | (356) | (18) | 695 | (636) | (905) | (629) | (878) | (1,102) |
| Net income | 297 | 255 | 1,120 | (4,340) | 1,287 | 3,722 | 3,160 | 3,481 | 5,099 |
| Income from continuing operationsno longer reported | 292 | 254 | 1,126 | (4,339) | 1,292 | 3,725 | 3,160 | 3,481 | |
| Net income attributable to noncontrolling interests | (230) | (221) | (220) | (199) | (173) | (162) | (158) | (186) | (337) |
| Loss from discontinued operations, net of taxno longer reported | 5 | 1 | (6) | (1) | (5) | (3) | 0 | 0 | |
| Net income attributable to McKesson Corporation | 67 | 34 | 900 | (4,539) | 1,114 | 3,560 | 3,002 | 3,295 | 4,762 |
| Earnings (loss) per common share attributable to McKesson Corporationera start | |||||||||
| Continuing operations (in dollars per share)no longer reported | 0.30 | 0.17 | 4.99 | (28.26) | 7.26 | 25.05 | 22.39 | 25.72 | |
| Diluted (in dollars per share) | 0.32 | 0.17 | 4.95 | (28.26) | 7.23 | 25.03 | 22.39 | 25.72 | 38.38 |
| Discontinued operations (in dollars per share)no longer reported | 0.02 | 0.00 | (0.04) | 0.00 | (0.03) | (0.02) | 0.00 | 0.00 | |
| Basic (in dollars per share) | 0.32 | 0.17 | 4.98 | (28.26) | 7.32 | 25.23 | 22.54 | 25.86 | 38.55 |
| Continuing operations (in dollars per share)no longer reported | 0.30 | 0.17 | 5.01 | (28.26) | 7.35 | 25.25 | 22.54 | 25.86 | |
| Weighted-average common shares outstandingera start | |||||||||
| Discontinued operations (in dollars per share)no longer reported | 0.02 | 0.00 | (0.03) | 0.00 | (0.03) | (0.02) | 0.00 | 0.00 | |
| Diluted (in shares) | 209 | 197.3 | 181.6 | 160.6 | 154.1 | 142.2 | 134.1 | 128.1 | 124.1 |
| Basic (in shares) | 208 | 196.3 | 180.6 | 160.6 | 152.3 | 141.1 | 133.2 | 127.4 | 123.6 |
History starts FY2018 (Mar), the period ended Mar 31, 2018 — the earliest period our structured-data source covers, not the company’s first year.
31 reported lines · 9 periods · values taken from the latest filing that prints each period.
- R3 restated by the filer — hover for the figure as first reported.
- italic25 from an earlier filing than the rest of the column.
- era start3 lines begin where our coverage begins.
- no longer reported12 lines the filer stopped printing.
- — the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.
241 of 244 values link to the exact element in the filer’s own document.
Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.
Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.